Patents by Inventor Jeffrey Poyser

Jeffrey Poyser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel compounds
    Publication number: 20070015819
    Abstract: The invention relates to thiophene carboxamides of formula (I), wherein A, R1, R2, R3, n and X are as defined in the specification, processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Application
    Filed: September 6, 2006
    Publication date: January 18, 2007
    Inventors: Alan Faull, Craig Johnstone, Andrew Morley, Jeffrey Poyser
  • Thiophene carboxamide compounds as inhibitors of enzyme IKK-2
    Patent number: 7125896
    Abstract: The invention relates to thiophene carboxanmides of formula (I), wherein A, R1, R2, R3, n and X are as defined in the specification, processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Grant
    Filed: July 19, 2002
    Date of Patent: October 24, 2006
    Assignee: AstraZeneca AB
    Inventors: Alan Faull, Craig Johnstone, Andrew Morley, Philip Jeffrey Poyser
  • Thiophene carboxanmides as inhibitors of the enzyme ikk-2
    Publication number: 20060111431
    Abstract: The invention relates to thiophene carboxamides of formula (I) wherein Ar, R1, R2, R3, R4, R5, m and n are as defined in the specification, processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Application
    Filed: January 13, 2004
    Publication date: May 25, 2006
    Inventors: Andrew Morley, Jeffrey Poyser
  • Thiophene-carboxamide derivatives and their use as inhibitors of the enzyme ikk-2
    Publication number: 20060058522
    Abstract: The invention relates to thiophene carboxamides of formula (I), wherein A, R1, R2, R3, R4, R5 and X are as defined in the specification, processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Application
    Filed: January 13, 2004
    Publication date: March 16, 2006
    Inventors: Alan Faull, Craig Johnstone, Andrew Morley, Jeffrey Poyser